Would it matter all that much @ArtirKel, if we made ageing a disease at the FDA?
-
Maybe what would rather need to change the way some of these therapies are accessed. Let's say TAME succeeds. What happens next, will MDs prescribe metformin for longevity to everyone? They don't have to. Will insurers reimburse it? And so forth
ive been harping on this for years-- but this all is downstream of running a single damn trial. the agency will bend their will to you if you can design, enroll, and complete a trial. No one in this space has meaningfully gotten past design, one wonders why.
